In the News

AGA releases recommendations on therapeutic drug monitoring in IBD

The recommendations call for drug monitoring in patients with active inflammatory bowel disease (IBD) who are starting thiopurines or having potentially related adverse events, among other recommendations.

Screening with flexible sigmoidoscopy reduces mortality risk, reanalysis concludes

The evidence supporting flexible sigmoidoscopy is substantially stronger than that for other screening methods and warrants reassessment of colorectal cancer screening guidelines, the authors of the reanalysis said.

Nearly all patients in study achieved sustained virologic response after 12 weeks of new HCV treatment

The drug combination appeared effective in adults with HCV genotypes 1, 2, 4, 5, or 6 infection and compensated cirrhosis in the industry-funded trial.

MKSAP quiz: 2-month history of upper abdominal discomfort after eating

This month's quiz asks readers to evaluate a 35-year-old man who recently returned from working in a rural area of a developing country.

Spotlight on nonalcoholic fatty liver disease and cardiac risk

Studies published in August examined the association between nonalcoholic steatohepatitis and heart failure and the effect of alcohol on cardiovascular risk in patients with nonalcoholic fatty liver disease.

HCV treatment by NPs, PCPs appears safe, effective as that provided by subspecialists

Reversing insurance restrictions that limit prescribing of direct-acting antivirals might allow rapid escalation of safe, effective therapy for hepatitis C virus (HCV) infection and could improve the care of patients, study authors noted.